MicroRNA-31 might predict lung-cancer spread
2013-09-25
(Press-News.org) COLUMBUS, Ohio – Determining whether a patient's lung cancer has spread to nearby lymph nodes is critical for identifying the most effective therapy, but it usually requires surgery. A new study suggests, however, that measuring levels of a particular molecule in a sample of tumor tissue might accurately answer the question.
Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) have discovered that levels of microRNA-31 (miR-31) predict the spread of the most common form of lung cancer to nearby lymph nodes.
They found that high levels of miR-31 in primary tumor cells predicted lymph node metastasis and poor survival in patients with non-small cell lung cancer (NSCLC). Low expression levels were associated with the absence of metastases and excellent survival.
The findings are published in the journal Clinical Cancer Research.
"Our findings suggest that microRNA expression in the primary lung tumor can estimate whether the tumor has spread to the lymph nodes and can help direct patients to the most appropriate treatment," says principal investigator Tim Lautenschlaeger, MD, a researcher in Radiation Oncology and the OSUCCC – James Experimental Therapeutics Program.
"Many patients undergo radiation therapy for NSCLC, and particularly those with early stage disease do not routinely undergo surgical staging," he explains. "Staging with positron emission tomography-computed tomography is very useful but not perfect. MiR-31 and other microRNAs can potentially improve our ability to correctly stage these patients.
"Additionally, if we can better estimate invasiveness of each patient's tumor, we could individualize treatment to include the invasive microscopic disease while sparing as much normal tissue as possible."
An estimated 228,190 cases of lung cancer are expected to occur in the United States in 2013, along with 159,500 deaths from the disease. NSCLC accounts for about 80 percent of all lung-cancer patients. Adenocarcinoma is the most common subtype, representing about 40 percent of all lung cancer cases.
MicroRNAs are a class of short, non-coding RNAs that regulate the translation or degradation of messenger RNA and therefore the proteins that cells make. Certain microRNAs are frequently dysregulated in cancer and are associated with tumor initiation and progression.
For this study, Lautenschlaeger and his colleagues examined samples of primary lung adenocarcinoma tissue from 43 patients. They analyzed 10 of these using genome-wide microRNA-sequencing; four of these cases had lymph node metastases and six were free of metastases.
Key technical findings included:
MiR-31 expression was four times higher in patients with lymph node metastases compared with those without them;
miR-31 increases cell migration, invasion and proliferation;
High miR-31 expression predicted poor survival, while low expression was associated with excellent survival.
"Overall, our findings provide a rationale to further evaluate microRNAs as biomarkers to determine which early-stage NSCLC patients treated with radiation therapy might benefit from additional cancer therapy," Lautenschlaeger says.
###
Funding from the NIH/ National Center for Advancing Translational Sciences (grant TR000090-05) supported this research.
Other researchers involved in this study were Wei Meng, Zhenqing Ye, Ri Cui, James Perry, Vaia Dedousi-Huebner, Alexander Huebner1, Yao Wang, Bin Li, Stefano Volinia, Hiroshi Nakanishi, Taewan Kim, Sung-Suk Suh, Leona W. Ayers, Patrick Ross, Carlo M. Croce, Arnab Chakravarti and Victor X. Jin of Ohio State.
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only seven centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State's cancer program as "exceptional," the highest rating given by NCI survey teams. As the cancer program's 210-bed adult patient-care component, The James is a "Top Hospital" as named by the Leapfrog Group and one of the top cancer hospitals in the nation as ranked by U.S. News & World Report.
ELSE PRESS RELEASES FROM THIS DATE:
Fat and obesity gene also affects hip fracture
2013-09-25
Australian researchers have demonstrated a strong association between the FTO (fat and obesity) gene and hip fracture in women. While the gene is already well known to affect diabetes and obesity, this is the first study to show that its high-risk variant can increase the risk of hip fracture by as much as 82%.
The study, undertaken by Dr Bich Tran and Professor Tuan Nguyen from Sydney's Garvan Institute of Medical Research, examined six gene variants (single nucleotide polymorphisms, or SNPs) of the FTO gene, taken from the DNA of 943 women in the Dubbo Osteoporosis ...
Ultra-fast electrons explain third radiation ring around Earth
2013-09-25
In the already complicated science of what creates – and causes constant change in – two giant doughnuts of radiation surrounding Earth, researchers have added a new piece of information: some of the electrons reach such enormous energies that they are driven by an entirely different set of physical processes. These results were published in a paper in Nature Physics on Sept. 22, 2013.
Understanding the nature of these radiation belts and how they swell and shrink over time is an integral part of interpreting, and perhaps someday predicting, the space weather that surrounds ...
Abiraterone acetate delays quality of life decline in men with metastatic prostate cancer
2013-09-25
CHAPEL HILL, N.C. -- Abiraterone acetate, a recently FDA-approved drug used to treat men with metastatic castration-resistant prostate cancer, significantly delays progression of pain and quality of life deterioration when taken in conjunction with prednisone.
The study, published Sept. 24 in Lancet Oncology, was led by Ethan Basch, MD, director of the Cancer Outcomes Research Program at the University of North Carolina Lineberger Comprehensive Cancer Center. Researchers measured the pain and quality of life impact of abiraterone acetate, an orally prescribed treatment ...
How the gut got its villi
2013-09-25
"You are not just a ball of cells," says Clifford Tabin, George Jacob and Jacqueline Hazel Leder Professor of Genetics at Harvard Medical School (HMS).
The way cells organize within the human body allows us all to function the way we do, but a couple of Harvard professors are concerned as much with that developmental process as with the end result. Tabin shares a common perspective with L. Mahadevan, the Lola England de Valpine Professor of Applied Mathematics at the Harvard School of Engineering and Applied Sciences (SEAS), professor of organismic and evolutionary biology, ...
Scientists push closer to understanding mystery of deep earthquakes
2013-09-24
LEMONT, Ill. – Scientists broke new ground in the study of deep earthquakes, a poorly understood phenomenon that occurs where the oceanic lithosphere, driven by tectonics, plunges under continental plates – examples are off the coasts of the western United States, Russia and Japan.
This research is a large step toward replicating the full power of these earthquakes to learn what sets them off and how they unleash their violence. It was made possible only by the construction of a one-of-a-kind X-ray facility that can replicate high-pressure and high-temperature while allowing ...
Early imaging, diagnosis of Alzheimer's leads to changes in patient care, better outcomes
2013-09-24
Patients suffering from early symptoms of Alzheimer's disease who were diagnosed sooner than usual using a brain imaging test received Alzheimer-specific medications earlier than those who did not have the brain imaging results available to their doctors or themselves. These patients also had significantly better clinical outcomes during the subsequent years they were clinically monitored, UCLA researchers have found for the first time.
The Metabolic Cerebral Imaging in Incipient Dementia study is an ongoing national clinical trial sponsored by the Centers for Medicare ...
UT Arlington researchers successfully test model for implant device reactions
2013-09-24
A team from The University of Texas at Arlington has used mathematical modeling to develop a computer simulation they hope will one day improve the treatment of dangerous reactions to medical implants such as stents, catheters and artificial joints.
The work resulted from a National Institutes of Health-funded collaboration by research groups headed by Liping Tang, professor of bioengineering in the UT Arlington College of Engineering, and Jianzhong Su, chairman and professor in the UT Arlington College of Science's mathematics department.
Results from their computational ...
Economic rewards of better land management: Estimated 2.3 billion tons of crops worth $1.4 trillion
2013-09-24
Adopting proven sustainable land management practices could raise world crop supplies by an estimated 2.3 billion tonnes, worth $1.4 trillion, experts say in a study being released at a major global desertification conference.
Conducted by the international Economics of Land Degradation initiative, the scientific interim report says land's economic value "is chronically undervalued and commonly determined by immediate agricultural or forestry market values."
"This focus on short-term gain motivates the highest extraction rates possible from land, leading to unsustainable ...
JCI early table of contents for Sept. 24, 2013
2013-09-24
Hereditary spastic paraplegia development associated with changes in endoplasmic reticulum
Hereditary spastic paraplegias (HSP) are a group of hereditary diseases that result in progressive loss of motor function in the lower limbs, and mutations in many different genes have been implicated in disease progression. One common feature of HSP is the progressive degradation of the axons of cortical motor neurons; however, it is not fully understood how mutations in is so many different genes result in axonal degradation. In this issue of the Journal of Clinical Investigation, ...
Hereditary spastic paraplegia development associated with changes in endoplasmic reticulum
2013-09-24
Hereditary spastic paraplegias (HSP) are a group of hereditary diseases that result in progressive loss of motor function in the lower limbs, and mutations in many different genes have been implicated in disease progression. One common feature of HSP is the progressive degradation of the axons of cortical motor neurons; however, it is not fully understood how mutations in is so many different genes result in axonal degradation.
In this issue of the Journal of Clinical Investigation, Christian Hübner and colleagues at Jena University develop a mouse model of HSP by introducing ...